The present invention provides non-alpha-tocopherol enriched tocopherol
compositions and non-alpha-tocopherol metabolite enriched compositions
for use in the reduction of inflammatory markers associated with
inflammation and for use in the treatment and/or amelioration of symptoms
of inflammation associated with for example, cardiovascular diseases or
disorders, infectious diseases, diabetes, SIRS, asthma, neurodegenerative
disorders, PMS; muscle fatigue or inflammation; and dermal conditions.
